Patent AT-E400303-T1: [Translated] COMBINED IMAGING CONTRAST AGENTS AND SYSTEMS AND METHODS THEREOF
In accordance with embodiments of the present technique, a combined modality imaging system (10) includes a first imaging device of a first modality (12) and a second imaging device of a second modality (14) that is different from the first modality (12). The first and the second imaging devices are both adapted to interact with a contrast agent (18) adapted to be received in a subject (16). The contrast agent (18) includes a deformable particle that has a geometry that varies in response to an emission from the first imaging device. The deformable particle also includes a fluorescent component (70) adapted to emit electromagnetic radiation (28) that is detectable by the second imaging device and a quenching component (72) separated from the fluorescent component (70) at a distance based on the geometry and that which is adapted to absorb a portion of the electromagnetic radiation (28) from the fluorescent component (70).
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[
"009:25"
]
|
| contactPoint |
{
"fn": "NIH/NCBI Data Team",
"@type": "vcard:Contact",
"hasEmail": "mailto:info@ncbi.nlm.nih.gov"
}
|
| description | In accordance with embodiments of the present technique, a combined modality imaging system (10) includes a first imaging device of a first modality (12) and a second imaging device of a second modality (14) that is different from the first modality (12). The first and the second imaging devices are both adapted to interact with a contrast agent (18) adapted to be received in a subject (16). The contrast agent (18) includes a deformable particle that has a geometry that varies in response to an emission from the first imaging device. The deformable particle also includes a fluorescent component (70) adapted to emit electromagnetic radiation (28) that is detectable by the second imaging device and a quenching component (72) separated from the fluorescent component (70) at a distance based on the geometry and that which is adapted to absorb a portion of the electromagnetic radiation (28) from the fluorescent component (70). |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Official Data Source",
"mediaType": "text/html",
"description": "Access the complete Patent AT-E400303-T1: [Translated] COMBINED IMAGING CONTRAST AGENTS AND SYSTEMS AND METHODS THEREOF on the official website.",
"downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400303-T1"
}
]
|
| identifier | https://healthdata.gov/api/views/pm8h-ugyb |
| issued | 2025-09-05 |
| keyword |
[
"chemistry",
"innovation",
"patent",
"pubchem",
"research"
]
|
| landingPage | https://healthdata.gov/d/pm8h-ugyb |
| modified | 2025-09-06 |
| programCode |
[
"009:066"
]
|
| publisher |
{
"name": "National Center for Biotechnology Information (NCBI)",
"@type": "org:Organization"
}
|
| theme |
[
"NIH"
]
|
| title | Patent AT-E400303-T1: [Translated] COMBINED IMAGING CONTRAST AGENTS AND SYSTEMS AND METHODS THEREOF |
